Amedisys - AMED EV/EBITDA Multiple

Amedisys Inc (AMED) - corporate logo

Amedisys, Inc. (AMED) holds a leading position in the US palliative care and home healthcare segment, focusing on patients with chronic pathologies. To combat labor shortages, the firm is implementing generous bonuses to attract nurses. This chart illustrating the price evolution of the stock shows that the EV/EBITDA multiple is . Business stability relies on employee care through flexible work schedules and mental health programs.

AMED Amedisys Health: Total Company Value to Operating Income Before Depreciation Ratio in the range 07/04/2022 - 11/12/2026

Analytical breakdowns for Amedisys, Inc.

- current price and projected stock value:
Stock Price Amedisys|AMED - Broker Consensus Forecast
- issuer market value details:
Market Capitalization AMED|AMED - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Amedisys|AMED - Book Valuation of Business|Market Cap to Net Assets Ratio amedisys.com|AMED - Company Assets
- company liabilities and liquidity data:
Debt to Equity Amedisys, Inc.|AMED - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Amedisys|AMED - Aggregate Debt Obligations|Debts to Book Capitalization AMED|AMED - Long-Term Debt Volume|Company Short-Term Debt Amedisys|Quick Ratio amedisys.com
- business earnings and investment ratios data:
AMED - Net Income|Future Profit Amedisys, Inc.|AMED - Business Payback Period|Forward P/E Multiple Amedisys|AMED - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AMED|AMED - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Amedisys|AMED - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth amedisys.com|AMED - Earnings per share growth this year|Earnings growth forecast for next year Amedisys, Inc.
Summary company analysis:Amedisys Health AMED
Original product of Amedisys Inc

This indicator reflects the ratio of total enterprise value to earnings before interest and taxes, allowing for an assessment of the real value of assets regardless of debt load. Analyzing the EV/EBITDA ratio of a company helps an investor determine a fair valuation range and avoid purchasing an asset at its peak value. For Amedisys, Inc. (AMED), such a metric is critically important during integration into healthcare holdings and the optimization of logistics through strategic alliances.

Analysis of competing companies

EV/EBITDA Multiple ELV (Anthem)|SCI: Enterprise Value to Operating Income Before Depreciation|The Ensign Group, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio chemed.com CHE|Bright Horizons Family Solutions (BFAM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BTSG - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ALHC|Company Value to EBITDA Addus ADUS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Brookdale Senior Living (BKD)|Total Company Value to Operating Income Before Depreciation Ratio nhccare.com|PACS Group - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GRDN|Aveanna Healthcare Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio LTC REIT LTC|Healthcare Services (HCSG) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MATW|CSV (Carriage Services) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InnovAge Holding Corp (INNV)|Enterprise Value to EBITDA Ratio SNDA (Capital Senior Living)|Total Company Value to Operating Income Before Depreciation Ratio Enhabit Corp|EV/EBITDA Multiple EJH (E-Home Household Service)